Nurse Practitioner, Family · Nampa, ID
NPI
1770538811
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
217 W Georgia Ave Ste 120
Nampa, ID, 83686
Phone (208) 498-1760
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
528 services
Medicare patients, 2024
75
Average age 58
Drug cost, 2024
$1.8M
5,508 prescriptions
Company payments, 2025
$1,335
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deo M Peppersack was code 99214 (office e&m - established), 266 times for 66 patients. In total Deo M Peppersack billed 528 services in 15 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 266 | 66 | $66.60 | $18K |
| 96372 Injection Administration | Office | 82 | 14 | $7.48 | $613 |
| 96127 Behavioral Health Services | Office | 65 | 35 | $3.09 | $201 |
| 99213 Office E&M - Established | Office | 45 | 20 | $47.27 | $2,127 |
| 36415 Venipuncture Blood Collection | Office | 16 | 13 | $8.65 | $138 |
| 90791 Psychotherapy - Nongroup | Office | 14 | 14 | $87.98 | $1,232 |
By year: 2022 $30K for 612 services; 2023 $29K for 590 services; 2024 $25K for 528 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 16 | 13 | $8.65 | $138 |
Medicare prescription drug claims, 2024
In 2024, the drug Deo M Peppersack prescribed most often to Medicare patients was Lamotrigine, with 251 prescriptions and refills. In total Deo M Peppersack wrote 5,508 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 251 | 269 | 45 | $2,194 |
| Trazodone Hcl Generic | 229 | 270 | 43 | $1,791 |
| Duloxetine Hcl Generic | 219 | 240 | 32 | $4,881 |
| Aripiprazole Generic | 180 | 199 | 38 | $21K |
| Quetiapine Fumarate Generic | 148 | 178 | 31 | $3,815 |
| Fluoxetine Hcl Generic | 143 | 165 | 22 | $910 |
| Vraylar Cariprazine Hcl | 141 | 142 | 25 | $202K |
| Clonidine Hcl Generic | 132 | 186 | 30 | $526 |
| Clonazepam Generic | 125 | 126 | 27 | $1,482 |
| Escitalopram Oxalate Generic | 118 | 166 | 28 | $924 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 106 | 106 | 19 | $3,259 |
| Levothyroxine Sodium Generic | 96 | 136 | 22 | $1,065 |
| Omeprazole Generic | 94 | 124 | 18 | $702 |
| Bupropion Xl Bupropion Hcl | 82 | 96 | 22 | $1,622 |
| Invega Sustenna Paliperidone Palmitate | 77 | 77 | 19 | $255K |
Brand drugs: - claims; generic drugs: 4,650 claims; opioid claims: 101.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deo M Peppersack $1,335 ($1,335 in general payments such as food, travel and fees) from 8 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $317.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 16 | $317 |
| Neurocrine BioSciences, Inc. NBIX | 26 | $267 |
| Teva Pharmaceuticals USA, Inc. TEVA | 13 | $245 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 16 | $221 |
| Abbvie Inc. ABBV | 33 | $204 |
| Corium, LLC | 8 | $50.03 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $15.4 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $15.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.